- Epiretinal Implants
- Subretinal Implants
Artificial retina is the medical device consists an array of microelectrodes. These devices are implanted into eyes of people those are blind due to the retinal disease. These devices are used in the retinal degenerative disease that causes the damage of photoreceptor cells of retina and leads to complete vision loss. Majorly occurring retinal degenerative diseases include retinitis pigmentosa and age-related macular degeneration. Retinal implants are made up of carbon nanotube biomimetic film with a transmitter and video processing units. These devices restore the vision by capturing light, convert into electrical signals and form an image by stimulating the neurons in retina.
Fastest Growing Market
Drivers: Increase in the prevalence of vision impaired patients, Development in economic growth, Expansion of business by market players. Restraints: Stringent regulatory policies for product approval, Product recall, High R&D expenditure.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.